Precise Insights

Advanced Data & AI for AML

On-demand access to the largest and most sophisticated oncology data for accelerated RWE and improved patient outcomes.

See some of the 1000s of data elements we offer:

Structured Fields

Request a Demo




Results from variety of patient tests


Oncology practice visits


Tumor-related observations plus vitals, biometrics, pain, and more


Surgeries, radiation, biopsies, imaging, transplants, etc.


Start and end dates, brand vs. generic codes, dosage, duration, and cycles

Social Determinants

Social and physical environment factors


Performance score


Disease state, status, severity, and metastasis

Expert Abstraction

Request a Demo


full ngs panel

Complete genomic report with treatment exposure and clinical outcomes

Disease Progression

Directly-observed measures of critical endpoints

Adverse Events

Confirm the adverse event and link to treatment discontinuation

Enriched Data

Request a Demo


Cost & Utilization

Adjudicated costs with linked claims data

Safety, Comorbidities

Pre-cancer and claims charge events

Specialty Pharmacy & Hub

Rx acquisition status details

Payer & Formulary

Drug tiers and coverage

AI & Model-Based Insights

Request a Demo


Cancer Subtype

Cancer type when ICD code is unknown

Date of Initial Dx

Impute index event

Line of Therapy

Regimen or progression-based drug classes

Patient Adherence

Identify root cause of product switching

Patient Acquisition

Predict factors driving patients’ brand decision

Request Data Count

Explore ConcertAI datasets to see how many patients are in your disease area and meet study criteria.